Equities

LAVA Therapeutics NV

LAVA Therapeutics NV

Actions
  • Price (USD)1.63
  • Today's Change-0.05 / -2.98%
  • Shares traded49.35k
  • 1 Year change-2.98%
  • Beta0.5100
Data delayed at least 15 minutes, as of Sep 20 2024 18:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

  • Revenue in USD (TTM)7.40m
  • Net income in USD-24.18m
  • Incorporated2016
  • Employees37.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Unicycive Therapeutics Inc0.00-24.41m40.57m14.00---------0.2843-0.28430.000.71930.00----0.00-68.77-218.20-118.93-609.54-------3,877.49----0.00---29.02---73.95------
Protara Therapeutics Inc0.00-40.69m40.64m26.00--0.4415-----3.19-3.190.004.460.00----0.00-41.35-37.02-43.70-38.29------------0.00------38.71---17.67--
Carisma Therapeutics Inc20.71m-72.50m40.74m107.00--113.16--1.97-1.78-1.780.50750.00870.2153----193,551.40-75.38-30.87-91.33-34.47-----350.08-255.66----0.8322---62.70---336.93--255.27--
HST Global Inc0.00-123.45k41.56m1.00---------0.0209-0.02090.00-0.00040.00-------3,300.80-5,836.01---------------27.315.81-------0.7858------
FibroGen Inc173.82m-168.32m41.77m486.00------0.2403-1.71-1.711.76-2.310.43011.2244.10357,644.00-42.40-30.62-89.79-42.3176.6593.52-98.60-119.081.24-12.47----4.99-7.053.21---20.67--
Kezar Life Sciences Inc7.00m-98.57m42.51m58.00--0.2818--6.07-1.35-1.350.09622.070.0316----120,689.70-44.47-32.54-47.84-34.09-----1,408.11-4,308.11----0.0634-------49.28--10.08--
DURECT Corp8.41m-15.80m42.52m47.00--8.44--5.06-0.5283-0.52830.28420.16230.21430.6827.26145,017.20-40.25-37.34-208.53-53.4480.8091.83-187.84-139.110.797-38.830.7135---55.67-10.9621.82---10.98--
Passage Bio Inc0.00-76.57m43.24m58.00--0.4774-----1.36-1.360.001.470.00----0.00-47.99-48.56-53.39-52.09------------0.00------25.02---43.53--
Reviva Pharmaceuticals Holdings, Inc.0.00-35.51m43.35m15.00---------1.30-1.300.00-0.20260.00----0.00-356.97---------------------------38.92------
Lantern Pharma Inc0.00-17.75m43.81m21.00--1.42-----1.65-1.650.002.870.00----0.00-40.79-28.83-44.71-30.17------------0.00-------11.93------
LAVA Therapeutics NV7.40m-24.18m44.17m37.00--1.03--5.97-0.8976-0.89760.27411.630.0689--3.23199,946.00-22.51---27.11--97.78---326.89------0.1257---65.09---31.55------
Calcimedica Inc0.00-12.59m44.51m14.00--3.22-----1.88-1.880.001.290.00----0.00-60.97-63.99-75.48-72.71------------0.00------3.51---44.35--
Atara Biotherapeutics Inc62.39m-181.05m44.91m165.00------0.7198-39.90-39.9013.06-22.610.3430.93142.60277,275.60-99.55-70.20-256.98-86.9480.14---290.20-1,559.330.2945-250.76-----86.51---20.95---49.14--
vTv Therapeutics Inc1.00m-20.18m44.94m16.00--2.73--44.94-6.81-6.810.27015.470.029--6.5462,500.00-73.77-111.84-170.69-------2,540.90-680.94----0.00---100.00---5.67------
Inotiv Inc501.06m-99.22m45.12m1.96k--0.2478--0.09-3.84-3.8419.447.000.6158.126.83256,297.70-12.11-23.84-19.28-29.2624.9329.31-19.70-33.240.2279-0.62340.6774--4.5285.1068.80--83.64--
Rallybio Corp299.00k-73.88m45.64m43.00--0.5703--152.63-1.79-1.790.00721.930.0025----6,953.49-61.57---67.23-------24,709.37------0.00-------11.87------
Data as of Sep 20 2024. Currency figures normalised to LAVA Therapeutics NV's reporting currency: US Dollar USD

Institutional shareholders

14.43%Per cent of shares held by top holders
HolderShares% Held
Redmile Group LLCas of 30 Jun 20242.07m7.89%
Bruce & Co., Inc.as of 30 Jun 2024771.87k2.94%
Sphera Funds Management Ltd.as of 30 Jun 2024367.58k1.40%
Zenito Oyas of 28 Jun 2024156.83k0.60%
Two Sigma Investments LPas of 30 Jun 2024112.44k0.43%
Alpha Wave Global LPas of 30 Jun 202487.40k0.33%
Citadel Securities LLCas of 30 Jun 202466.24k0.25%
PNC Bank, NA (Investment Management)as of 30 Jun 202465.00k0.25%
Pathway Financial Advisors LLCas of 30 Jun 202460.00k0.23%
Two Sigma Advisers LPas of 30 Jun 202431.70k0.12%
More ▼
Data from 28 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.